Full Year 2025 Total Revenues of $589.0 Million, Representing 19.8% Year-Over-Year Growth and Marking Another Year of Record Total RevenuesQ4 ...
Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry ...
Despite continued uncertainty and mounting regulatory challenges, pharma TV ad spend topped $7 billion through the first 11 months of 2025. Recently released data by iSpot.tv found that the ...
Pharmaceutical Technology on MSN
Podcast: Which pharma and medtech companies came out on top in 2025 revenues?
The healthcare editorial teams discusses the key trends and growth drivers in companies' recent 2025 financial results.
Q4 2025 product revenue of €240 million and FY 2025 product revenue of €684 millionQ4 2025 operating profit of €10 million and cash flow from ...
Looking back on 2025, a lot happened in the world of healthcare. This year was largely defined by the arrival of the second Trump administration, armed with tariff threats, unorthodox views about ...
It’s been another whirlwind year in the world of pharma marketing. The year’s most enduring narratives revolved around industrywide shifts heavily influenced by Trump administration directives: a ...
EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) said it will report fourth-quarter and full-year 2025 financial results before the market opens Thursday, February 12, 2026, setting the ...
The pharmaceutical sector is entering 2026 at a critical juncture. While recent initial public offering (IPO) performance has been stellar, with pharma firms claiming five of the top 10 IPO returns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results